292 related articles for article (PubMed ID: 25332241)
1. Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.
Wilk A; Wyczechowska D; Zapata A; Dean M; Mullinax J; Marrero L; Parsons C; Peruzzi F; Culicchia F; Ochoa A; Grabacka M; Reiss K
Mol Cell Biol; 2015 Jan; 35(1):182-98. PubMed ID: 25332241
[TBL] [Abstract][Full Text] [Related]
2. NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells.
Han D; Wei W; Chen X; Zhang Y; Wang Y; Zhang J; Wang X; Yu T; Hu Q; Liu N; You Y
Oncotarget; 2015 Sep; 6(28):26119-28. PubMed ID: 26172294
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier.
Grabacka M; Waligorski P; Zapata A; Blake DA; Wyczechowska D; Wilk A; Rutkowska M; Vashistha H; Ayyala R; Ponnusamy T; John VT; Culicchia F; Wisniewska-Becker A; Reiss K
J Physiol Pharmacol; 2015 Apr; 66(2):233-47. PubMed ID: 25903954
[TBL] [Abstract][Full Text] [Related]
4. ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro.
Drukala J; Urbanska K; Wilk A; Grabacka M; Wybieralska E; Del Valle L; Madeja Z; Reiss K
Mol Cancer; 2010 Jun; 9():159. PubMed ID: 20569465
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro.
Wilk A; Urbanska K; Grabacka M; Mullinax J; Marcinkiewicz C; Impastato D; Estrada JJ; Reiss K
Cell Cycle; 2012 Jul; 11(14):2660-71. PubMed ID: 22732497
[TBL] [Abstract][Full Text] [Related]
7. The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomas.
Zhu W; Zhao H; Xu F; Huang B; Dai X; Sun J; Nyalali AMK; Zhang K; Ni S
BMC Cancer; 2021 Jun; 21(1):664. PubMed ID: 34082742
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of proapoptotic and autophagic proteins involved in the cell death of glioblastoma induced by synthetic glycans.
Faried A; Arifin MZ; Ishiuchi S; Kuwano H; Yazawa S
J Neurosurg; 2014 Jun; 120(6):1298-308. PubMed ID: 24678780
[TBL] [Abstract][Full Text] [Related]
9. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Kar D; Bandyopadhyay A
Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate inhibits endothelin-1 expression by peroxisome proliferator-activated receptor α-dependent and independent mechanisms in human endothelial cells.
Glineur C; Gross B; Neve B; Rommens C; Chew GT; Martin-Nizard F; Rodríguez-Pascual F; Lamas S; Watts GF; Staels B
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):621-8. PubMed ID: 23329136
[TBL] [Abstract][Full Text] [Related]
11. The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes.
Xing F; Luan Y; Cai J; Wu S; Mai J; Gu J; Zhang H; Li K; Lin Y; Xiao X; Liang J; Li Y; Chen W; Tan Y; Sheng L; Lu B; Lu W; Gao M; Qiu P; Su X; Yin W; Hu J; Chen Z; Sai K; Wang J; Chen F; Chen Y; Zhu S; Liu D; Cheng S; Xie Z; Zhu W; Yan G
Cell Rep; 2017 Jan; 18(2):468-481. PubMed ID: 28076790
[TBL] [Abstract][Full Text] [Related]
12. HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
Li H; Li J; Chen L; Qi S; Yu S; Weng Z; Hu Z; Zhou Q; Xin Z; Shi L; Ma L; Huang A; Lu Y
Clin Cancer Res; 2019 Jun; 25(12):3602-3616. PubMed ID: 30862693
[TBL] [Abstract][Full Text] [Related]
13. MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma.
Zhang Y; Nguyen TTT; Shang E; Mela A; Humala N; Mahajan A; Zhao J; Shu C; Torrini C; Sanchez-Quintero MJ; Kleiner G; Bianchetti E; Westhoff MA; Quinzii CM; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
Cancer Res; 2020 Jan; 80(1):30-43. PubMed ID: 31694905
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate induces G0/G1 phase arrest by modulating the PPARα/FoxO1/p27 kip pathway in human glioblastoma cells.
Han DF; Zhang JX; Wei WJ; Tao T; Hu Q; Wang YY; Wang XF; Liu N; You YP
Tumour Biol; 2015 May; 36(5):3823-9. PubMed ID: 25566967
[TBL] [Abstract][Full Text] [Related]
15. Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor α: implications for late infantile Batten disease therapy.
Ghosh A; Corbett GT; Gonzalez FJ; Pahan K
J Biol Chem; 2012 Nov; 287(46):38922-35. PubMed ID: 22989886
[TBL] [Abstract][Full Text] [Related]
16. Modulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrate.
Li P; Luo S; Pan C; Cheng X
Mol Med Rep; 2015 Dec; 12(6):7899-906. PubMed ID: 26497978
[TBL] [Abstract][Full Text] [Related]
17. Metabolic modulation of glioblastoma with dichloroacetate.
Michelakis ED; Sutendra G; Dromparis P; Webster L; Haromy A; Niven E; Maguire C; Gammer TL; Mackey JR; Fulton D; Abdulkarim B; McMurtry MS; Petruk KC
Sci Transl Med; 2010 May; 2(31):31ra34. PubMed ID: 20463368
[TBL] [Abstract][Full Text] [Related]
18. PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.
Panigrahy D; Kaipainen A; Huang S; Butterfield CE; Barnés CM; Fannon M; Laforme AM; Chaponis DM; Folkman J; Kieran MW
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):985-90. PubMed ID: 18199835
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy.
Yoo J; Jeong IK; Ahn KJ; Chung HY; Hwang YC
Metabolism; 2021 Jul; 120():154798. PubMed ID: 33984335
[TBL] [Abstract][Full Text] [Related]
20. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
